Use of benzimidazole chemotherapy in human helminthiases: indications and efficacy.
The past two decades have seen some remarkable developments in anthelmintic chemotherapy in clinical medicine. Whereas praziquantel has revolutionized the management of many cestode and trematode infections, Gordon Cook explains how the introduction of the benzimidazoles - most importantly thiabendazole, mebendazole and recently albendazole (flubendazole, cambendazole, ciclobendazole, and triclabendazole have also been used on a very limited scale) - has had a major impact upon the safe and effective management of several important intestinal and systemic nematode and, to a leser extent, cestode infections.[1]References
- Use of benzimidazole chemotherapy in human helminthiases: indications and efficacy. Cook, G.C. Parasitol. Today (Regul. Ed.) (1990) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg